Lv11
40 积分 2022-12-04 加入
T-cell-engaging bispecific antibodies in cancer
11小时前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
5个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
5个月前
已完结
Production of Class II MHC Proteins in Lentiviral Vector‐Transduced HEK‐293T Cells for Tetramer Staining Reagents
6个月前
已完结
CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes
7个月前
已完结
Antigen-specific therapeutic approaches for autoimmunity
7个月前
已完结
Selection of High-Producing Clones Using FACS for CHO Cell Line Development
10个月前
已完结
Cancer neoantigen: Boosting immunotherapy
1年前
已完结
Recent advances in personalized cancer immunotherapy with immune checkpoint inhibitors, T cells and vaccines
1年前
已完结
Challenges in developing personalized neoantigen cancer vaccines
1年前
已完结
皖公网安备34019202002308
